Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_assertion type Assertion NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_head.
- NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_assertion description "[We then assessed the relation of allelic variants of genes modulating clopidogrel absorption (ABCB1), metabolic activation (CYP3A5 and CYP2C19), and biologic activity (P2RY12 and ITGB3) to the risk of death from any cause, nonfatal stroke, or myocardial infarction during 1 year of follow-up.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_provenance.
- NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_assertion evidence source_evidence_literature NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_provenance.
- NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_assertion SIO_000772 19106083 NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_provenance.
- NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_assertion wasDerivedFrom gad-20150221 NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_provenance.
- NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_assertion wasGeneratedBy ECO_0000203 NP111437.RAu_WsYIF8FZEeyvn2Yw6kzgRItEc-pSc6mRmH--CYZ7E130_provenance.